Výsledky vyhľadávania - "PLATELET INHIBITION"

Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation: A nationwide observational study from the SWEDEHEART registry

Autori: Skibniewski, Mikolaj Venetsanos, Dimitrios Ahlsson, Anders a ďalší

Zdroj: American Heart Journal. 257:69-77

Predmety: Antithrombotic therapy, Atrial fibrillation, CABG, Oral anticoagulation, Platelet inhibition

Popis súboru: electronic

Prístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-491402
https://doi.org/10.1016/j.ahj.2022.12.001

Evaluation of the effects and plasma concentration of the platelet inhibitor ticagrelor, after crushed and non-crushed intake, after cardiac arrest and after semi-urgent coronary artery bypass surgery

Autori: Lukas Duvillier Carl Verhaege Katrien M. J. Devreese a ďalší

Zdroj: ACTA CARDIOLOGICA

Predmety: Male, PHARMACOKINETICS, Ticagrelor, Platelet Function Tests, ACS patients, PHARMACODYNAMICS, Middle Aged, PROFILE, platelet inhibition, crushed tablets, Heart Arrest, Treatment Outcome, TUBE, CLOPIDOGREL, Ticragelor concentration, Medicine and Health Sciences, Humans, Female, Acute Coronary Syndrome, Coronary Artery Bypass, Platelet Aggregation Inhibitors, Aged

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39377148
https://biblio.ugent.be/publication/01JYKDEY5S8QGAT1V74BZ55X3D/file/01JYKDFK0YSGZ5EMA6K1BPKK6V
https://biblio.ugent.be/publication/01JYKDEY5S8QGAT1V74BZ55X3D
http://hdl.handle.net/1854/LU-01JYKDEY5S8QGAT1V74BZ55X3D
http://doi.org/10.1080/00015385.2024.2409521

Clopidogrel transfer into human milk: case series – a contribution from the ConcePTION project: case series - a contribution from the ConcePTION project

Autori: Martje Van Neste Nina Nauwelaerts Raf Mols a ďalší

Zdroj: Front Pharmacol
Frontiers in Pharmacology, Vol 16 (2025)
Frontiers in Pharmacology

Predmety: RISK, Pharmacology, clopidogrel carboxylic acid (CCA), YOUNG-CHILDREN, clopidogrel, Science & Technology, breastfeeding, 3214 Pharmacology and pharmaceutical sciences, case series, INFANTS, human milk, clopidogrel active metabolite (CAM), RM1-950, METABOLITE, SDG 3 - Good Health and Well-being, PLATELET INHIBITION, Pharmacology & Pharmacy, Therapeutics. Pharmacology, 1115 Pharmacology and Pharmaceutical Sciences, cerebral vascular accident (CVA), Life Sciences & Biomedicine, pharmacokinetics

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40235546
https://doaj.org/article/08ace936c5444b9eb85930005e755661

No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response

Autori: Maria J. Reimann Daniel N. Faisst Mads Knold a ďalší

Zdroj: J Vet Intern Med
Journal of Veterinary Internal Medicine, Vol 37, Iss 6, Pp 2145-2156 (2023)
Reimann, M J, Faisst, D N, Knold, M, Meurs, K M, Stern, J A, Cremer, S E, Møller, J E, Ljungvall, I, Häggström, J & Olsen, L H 2023, ' No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response ', Journal of Veterinary Internal Medicine, vol. 37, no. 6, pp. 1947-2660 . https://doi.org/10.1111/jvim.16871

Predmety: Cyclic Nucleotide Phosphodiesterases, Type 5, dogs, Platelet Aggregation, Veterinary medicine, Heart Valve Diseases, heart disease, Clinical Science, platelet inhibition, 3. Good health, Dogs, genetic variation, SF600-1100, Animals, SMALL ANIMAL, Dog Diseases, light transmission aggregometry, pharmacogenetics

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37743723
https://doaj.org/article/cd502d1817ad4c5a967b5c356fee7e03
https://pub.epsilon.slu.se/33077/
https://curis.ku.dk/ws/files/381929381/Veterinary_Internal_Medicne_2023_Reimann_No_impact_of_polymorphism_in_the_phosphodiesterase_5A_gene_in_Cavalier_King.pdf

CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel

Autori: Kiiski Johanna I. Sinisalo Juha Ramste Markus a ďalší

Prispievatelia: Kiiski Johanna I. Sinisalo Juha Ramste Markus a ďalší

Zdroj: Clin Transl Sci
Clinical and Translational Science, Vol 16, Iss 10, Pp 2010-2020 (2023)

Predmety: Ticagrelor, Platelet inhibition, Genotype, Proton pump inhibitors, Events, RM1-950, Association, Humans, Prospective Studies, Clinical-outcomes, Pantoprazole, Alleles, Research, Esomeprazole, General medicine, internal medicine and other clinical medicine, 3. Good health, Phenoconversion, Clopidogrel, Cytochrome P-450 CYP2C19, Stroke, Impact, Treatment Outcome, Therapeutics. Pharmacology, Public aspects of medicine, RA1-1270, Platelet Aggregation Inhibitors, Omeprazole

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37551775
https://doaj.org/article/ebb5f4676e22413aad2e3b7c6e59dfd7
http://hdl.handle.net/10138/567752

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

Autori: Sahlen, Anders Varenhorst, Christoph Lagerqvist, Bo a ďalší

Zdroj: European Heart Journal. 37(44):3335-3342

Predmety: Acute coronary syndrome, Platelet inhibition, Ticagrelor

Popis súboru: electronic

Prístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-317706
https://uu.diva-portal.org/smash/get/diva2:1082637/FULLTEXT01.pdf

Effect of clopidogrel on post extraction clotting in patients on dual antiplatelet therapy

Autori: Zhang, Yaqiong Zhao, Yijie Zhao Wang, Meng a ďalší

Zdroj: Tropical Journal of Pharmaceutical Research; Vol. 22 No. 1 (2023); 189-197

Predmety: Dual antiplatelet therapy, Clopidogrel responsiveness, Dental extraction, Post-extraction clotting, Thromboelastography platelet mapping assay, Platelet inhibition

Popis súboru: application/pdf

Prístupová URL adresa: https://www.ajol.info/index.php/tjpr/article/view/241858

Cangrelor to optimise platelet inhibition in STEMI patients pre-treated with ticagrelor: a Sisyphean task?

Predmety: ST-elevation myocardial infarction, Primary percutaneous coronary intervention, Cardiology (incl. cardiovascular diseases), Cangrelor, STEMI patients, platelet inhibition, ticagrelor, Clinical pharmacology and therapeutics

Prístupová URL adresa: https://figshare.com/articles/Cangrelor_to_optimise_platelet_inhibition_in_STEMI_patients_pre-treated_with_ticagrelor_a_Sisyphean_task_/25297999/1
https://hdl.handle.net/10779/rcsi.25297999.v1

Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide registry-based study

Autori: Sissel J Godtfredsen Kristian H Kragholm Peter Leutscher a ďalší

Zdroj: Godtfredsen, S J, Kragholm, K H, Leutscher, P, Jørgensen, S H, Christensen, M K, Butt, J H, Gislason, G, Køber, L, Fosbøl, E L, Sessa, M, Bhatt, D L, Torp-Pedersen, C & Pareek, M 2022, 'Effectiveness and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention : a nationwide registry-based study', European Heart Journal: Acute Cardiovascular Care, vol. 11, no. 9, zuac095, pp. 697-705. https://doi.org/10.1093/ehjacc/zuac095

Predmety: Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, ST Elevation Myocardial Infarction/drug therapy, PREHOSPITAL TICAGRELOR, Hemorrhage, Clopidogrel/therapeutic use, VALIDATION, Prasugrel Hydrochloride/therapeutic use, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Hemorrhage/chemically induced, Humans, Registries, Percutaneous Coronary Intervention/adverse effects, OUTCOMES, Aspirin, DUAL ANTIPLATELET THERAPY, OPEN-LABEL, RANDOMIZED-TRIAL, Clopidogrel, 3. Good health, Treatment Outcome, Ticagrelor/therapeutic use, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists, PLATELET INHIBITION, ST Elevation Myocardial Infarction, REVASCULARIZATION, Prasugrel, Prasugrel Hydrochloride, Platelet Aggregation Inhibitors, ST-segment myocardial infarction

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35950769
https://vbn.aau.dk/da/publications/19f3f161-9804-4191-9547-e2c3e620f7f9
https://doi.org/10.1093/ehjacc/zuac095

Panax quinquefolius saponins combined with dual antiplatelet therapy enhanced platelet inhibition with alleviated gastric injury via regulating eicosanoids metabolism

Autori: Wenting Wang Lei Song Lin Yang a ďalší

Zdroj: BMC Complementary Medicine and Therapies, Vol 23, Iss 1, Pp 1-14 (2023)

Predmety: Panax quinquefolius saponins, Dual antiplatelet therapy, Platelet inhibition, Gastric injury, Lipidomics, Eicosanoids, Other systems of medicine, RZ201-999

Popis súboru: electronic resource

Relation: https://doaj.org/toc/2662-7671

Prístupová URL adresa: https://doaj.org/article/bca46420e5fe4df2bbcb597400585d07

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

Autori: Lindholm, Daniel Varenhorst, Christoph Cannon, Christopher P. a ďalší

Zdroj: European Heart Journal. 35(31):2083-2093

Predmety: Platelet inhibition, Acute coronary syndrome

Popis súboru: electronic

Prístupová URL adresa: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-235190
https://uu.diva-portal.org/smash/get/diva2:759455/FULLTEXT01.pdf

Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation

Autori: Martina Aguiar Bucsai Christian Idel Barbara Wollenberg a ďalší

Zdroj: Platelets, Vol 33, Iss 8, Pp 1192-1198 (2022)

Predmety: Blood Platelets, tirofiban, Platelet Aggregation, Platelet Glycoprotein GPIIb-IIIa Complex, Platelet Activation, platelet inhibition, P-Selectin, 03 medical and health sciences, 0302 clinical medicine, Tirofiban, platelet aggregation, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, platelet activation, Humans, Tyrosine, Diseases of the blood and blood-forming organs, Receptors, Thrombin, RC633-647.5, Chemokine CCL5, platelet degranulation, Platelet Aggregation Inhibitors

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35701857
https://doaj.org/article/67d154783c2d4217a594f18f8ee8fe79

Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength

Autori: Wilbert L. Jones Christopher R. Ramos Anirban Banerjee a ďalší

Zdroj: Platelets, Vol 33, Iss 8, Pp 1119-1131 (2022)

Predmety: Blood Platelets, CD36 Antigens, Arachidonic Acid, Apolipoprotein A-I, Platelet Aggregation, microfluidics, Thrombosis, Platelet Activation, platelet inhibition, 3. Good health, Mice, P-Selectin, 03 medical and health sciences, 0302 clinical medicine, thrombelastography, sr-b1 receptor, hyperfibrinolysis, Animals, Humans, Diseases of the blood and blood-forming organs, RC633-647.5, Pulmonary Embolism, Proto-Oncogene Proteins c-akt

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35659185
https://doaj.org/article/431566e32a634e068a99c0c4b4495a3e

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial: Insights from the GLOBAL LEADERS trial

Autori: Masafumi Ono Yoshinobu Onuma Hideyuki Kawashima a ďalší

Prispievatelia: Masafumi Ono Yoshinobu Onuma Hideyuki Kawashima a ďalší

Zdroj: Catheter Cardiovasc Interv
Ono, Masafumi; Onuma, Yoshinobu; Kawashima, Hideyuki; Hara, Hironori; Gao, Chao; Wang, Rutao; O'Leary, Neil; Benit, Edouard; Janssens, Luc; Ferrario, Maurizio; Żurakowski, Aleksander; Dominici, Marcello; Huber, Kurt; Buszman, Paweł; Garg, Scot; Wykrzykowska, Joanna J; Piek, Jan J; Jüni, Peter; Hamm, Christian; Windecker, Stephan; ... (2022). Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions, 100(1), pp. 72-82. Wiley 10.1002/ccd.30217 <http://dx.doi.org/10.1002/ccd.30217>

Predmety: Ticagrelor, proton pump inhibitor, FOCUSED UPDATE, Myocardial Infarction, 610 Medicine & health, Coronary Artery Disease, THERAPY, DEFINITIONS, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Humans, ticagrelor monotherapy, RISK, drug interaction, OUTCOMES, Aspirin, percutaneous coronary intervention, OMEPRAZOLE, Proton Pump Inhibitors, dual antiplatelet therapy, 3. Good health, Treatment Outcome, CLOPIDOGREL, PLATELET INHIBITION, CLINICAL-TRIALS, Platelet Aggregation Inhibitors

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35500171
https://research.rug.nl/en/publications/edcfd4b0-09f6-42f2-887b-5c110ade4733
https://hdl.handle.net/11370/edcfd4b0-09f6-42f2-887b-5c110ade4733
https://doi.org/10.1002/ccd.30217
https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.30217
https://doi.org/10.1002/ccd.30217
https://pure.amsterdamumc.nl/en/publications/a50a8ca6-bcdb-41a8-9412-aacc3bf63b97
https://doi.org/10.1002/ccd.30217
https://boris.unibe.ch/169687/
http://hdl.handle.net/1942/37465

Risk factors for hemorrhage in patients with long-term aspirin therapy undergoing emergency external ventricular drainage/intracranial pressure probe placement

Autori: Fei Gao Shunnan Ge Wenxing Cui a ďalší

Zdroj: Heliyon, Vol 10, Iss 5, Pp e26854- (2024)

Predmety: Aspirin, Thromboelastography, Platelet inhibition rate, External ventricular drainage, Intracranial pressure, Hemorrhage, Science (General), Q1-390, Social sciences (General), H1-99

Popis súboru: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024028858; https://doaj.org/toc/2405-8440

Prístupová URL adresa: https://doaj.org/article/df1fb4b5f0134b1f9c857ac4eacac4c0

Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study

Autori: Giuseppe Gargiulo Plinio Cirillo Luca Sperandeo a ďalší

Zdroj: International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101344- (2024)

Predmety: STEMI, Primary PCI, Cangrelor, Pharmacodynamic assessment, Platelet inhibition, Ticagrelor pretreatment, Diseases of the circulatory (Cardiovascular) system, RC666-701

Popis súboru: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352906724000101; https://doaj.org/toc/2352-9067

Prístupová URL adresa: https://doaj.org/article/165157f62580481a8b26660fa57779c6

Sjælden type subaraknoidal blødning som årsag til svære rygsmerter

Autori: Metzler, Emma Katrine Richall, Humeira Simony, Ane

Zdroj: Dansk Tidsskrift for Akutmedicin; Vol. 7 No. 2 (2024): Juli 2024; 32-25 ; Dansk Tidsskrift for Akutmedicin; Årg. 7 Nr. 2 (2024): Juli 2024; 32-25 ; 2596-545X

Predmety: Subarachnoid hemorrhage, spinal hemorrhage, acute back pain, platelet inhibition treatment

Popis súboru: application/pdf

Relation: https://tidsskrift.dk/akut/article/view/142299/190371; https://tidsskrift.dk/akut/article/view/142299/190374; https://tidsskrift.dk/akut/article/view/142299

Dostupnosť: https://tidsskrift.dk/akut/article/view/142299

Immediate Platelet Inhibition Strategy for Comatose Out-of-Hospital Cardiac Arrest Survivors Undergoing Percutaneous Coronary Intervention and Mild Therapeutic Hypothermia

Autori: Peter Kordis Jernej Berden Ursa Mikuz a ďalší

Zdroj: Journal of Clinical Medicine, Vol 13, Iss 7, p 2121 (2024)

Predmety: cangrelor, cardiac arrest, platelet inhibition, percutaneous coronary intervention, stent thrombosis, Medicine

Relation: https://www.mdpi.com/2077-0383/13/7/2121; https://doaj.org/toc/2077-0383; https://doaj.org/article/a3a2e95ebd5249cc967e11f0e548ee70

Dostupnosť: https://doi.org/10.3390/jcm13072121
https://doaj.org/article/a3a2e95ebd5249cc967e11f0e548ee70

Ruthenium Antivenom Inhibits the Defibrinogenating Activity of Crotalus adamanteus Venom in Rabbits

Autori: Vance G. Nielsen

Zdroj: International Journal of Molecular Sciences, Vol 25, Iss 12, p 6334 (2024)

Predmety: snake venom thrombin-like enzyme, thrombelastography, rabbit, platelet inhibition, ruthenium, Biology (General), QH301-705.5, Chemistry, QD1-999

Relation: https://www.mdpi.com/1422-0067/25/12/6334; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/01dddb4e27b244ce9c92f5b71de7c6a6

Dostupnosť: https://doi.org/10.3390/ijms25126334
https://doaj.org/article/01dddb4e27b244ce9c92f5b71de7c6a6

Intrazerebrale Blutungen unter Plättchenaggregationshemmung und oraler Antikoagulation bei Patienten mit zerebraler Amyloidangiopathie

Autori: Haußmann, R. Homeyer, P. Haußmann, M. a ďalší

Zdroj: Nervenarzt
Der Nervenarzt 93(6), 599-604 (2022). doi:10.1007/s00115-021-01206-w

Predmety: therapeutic use [Anticoagulants], complications [Atrial Fibrillation], Interventional left atrial appendage closure, Platelet inhibition, Oral anticoagulation, 03 medical and health sciences, 0302 clinical medicine, Atrial Fibrillation, Humans, drug therapy [Atrial Fibrillation], complications [Stroke], ddc:610, Cerebral amyloid angiopathy, Cerebral Hemorrhage, Ischemic Stroke, Atrial Fibrillation/complications [MeSH], Humans [MeSH], Orale Antikoagulation, Interventioneller Vorhofohrverschluss, Übersichten, Atrial Fibrillation/drug therapy [MeSH], Stroke/complications [MeSH], Cerebrale Amyloidangiopathie, Ischemic Stroke [MeSH], Thrombozytenaggregationshemmung, Cerebral Amyloid Angiopathy/complications [MeSH], Cerebral Hemorrhage/complications [MeSH], Cerebral Amyloid Angiopathy/drug therapy [MeSH], Intracerebral hemorrhage, Anticoagulants/therapeutic use [MeSH], Cerebral Hemorrhage/chemically induced [MeSH], Cerebral Hemorrhage/diagnosis [MeSH], Intracerebrale Blutung, Cerebral Amyloid Angiopathy/diagnosis [MeSH], diagnosis [Cerebral Hemorrhage], diagnosis [Cerebral Amyloid Angiopathy], chemically induced [Cerebral Hemorrhage], Anticoagulants, 3. Good health, Stroke, Cerebral Amyloid Angiopathy, complications [Cerebral Hemorrhage], drug therapy [Cerebral Amyloid Angiopathy], complications [Cerebral Amyloid Angiopathy]

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00115-021-01206-w.pdf
https://pubmed.ncbi.nlm.nih.gov/34652485
https://pubmed.ncbi.nlm.nih.gov/34652485/
https://link.springer.com/content/pdf/10.1007/s00115-021-01206-w.pdf
https://link.springer.com/article/10.1007/s00115-021-01206-w
https://pub.dzne.de/record/162912
https://repository.publisso.de/resource/frl:6448119